7/16/2009

Animas, a Johnson & Johnson subsidiary, received approval from Health Canada to sell its OneTouch Ping glucose-management system. The device, which was approved by the FDA in 2008, allows diabetic patients to measure insulin doses and wirelessly alert the insulin pump to release insulin.

Related Summaries